GILD Scores FDA Win for HDV Drug, CHMP Backs Trodelvy
25/5 16:59
Gilead wins FDA approval for Hepcludex, the first U.S. therapy for chronic HDV, while Trodelvy advances in Europe for TNBC....
|
|
|
25/5 16:59
Gilead wins FDA approval for Hepcludex, the first U.S. therapy for chronic HDV, while Trodelvy advances in Europe for TNBC....